Wealth Growth Daily

Health

Pepsico recalls some Starbucks vanilla frappuccino drinks in U.S

BY Reuters  • February 19, 2023February 19, 2023
(Reuters) – Pepsico Inc recalled more than 25,000 cases of Starbucks chilled coffee drink after glass was found in some of the bottles, the U.S. Food and Drug administration said in a notice. Th[...]
Read more
Business Health Top News US

Analysis-Germany’s oldest companies face fresh break-up calls

BY Reuters  • February 16, 2023February 16, 2023
By Christoph Steitz and Ludwig Burger FRANKFURT (Reuters) – Activist investors are renewing their years-long efforts to break up some of Germany’s most venerable companies, seeing streamli[...]
Read more
Business Economy Europe Health Updated US

China’s Jan air passenger numbers jump 34.8% after COVID curbs ease

BY Reuters  • February 16, 2023February 16, 2023
BEIJING (Reuters) – China’s January air passenger traffic rose 34.8% from a year earlier, the aviation regulator said at a regular news conference on Thursday, after the country abandoned[...]
Read more
Asia Business Economy Health

U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit

BY Reuters  • February 15, 2023February 15, 2023
By Blake Brittain (Reuters) – The U.S. government should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on T[...]
Read more
Business Health US

Biogen sees modest 2023 revenue from Alzheimer’s disease drug

BY Reuters  • February 15, 2023February 15, 2023
By Manas Mishra (Reuters) -Biogen Inc said on Wednesday that Alzheimer’s disease drug Leqembi would bring in modest revenue for the year although it might not be enough to offset costs tied to i[...]
Read more
Asia Business Economy Europe Health UK Updated US

Soros Fund adds First Horizon, Horizon Therapeutics and bond ETF

BY Reuters  • February 14, 2023February 14, 2023
By Carolina Mandl NEW YORK (Reuters) – Soros Fund Management, the family office of billionaire George Soros, added to its portfolio new shares in financial and healthcare companies and a bonds e[...]
Read more
Business Economy Europe Health US

Johnson & Johnson names ex-Sanofi executive as pharma, R&D vice president

BY Reuters  • February 13, 2023February 13, 2023
(Reuters) – Johnson & Johnson said on Monday John Reed will take the role of executive vice president of pharmaceuticals, research and development, effective April 3. Reed, 64, will replace[...]
Read more
Business Europe Health US

Thousands of J&J talc lawsuits in New Jersey get new judge

BY Reuters  • February 13, 2023February 13, 2023
By Brendan Pierson (Reuters) – A new judge has been assigned to oversee tens of thousands of lawsuits in New Jersey federal court against Johnson & Johnson over its talc products, two weeks[...]
Read more
Business Health Updated US

Alcon to pay Johnson & Johnson $199 million to settle eye-laser cases

BY Reuters  • February 13, 2023February 13, 2023
By Blake Brittain (Reuters) – Alcon Vision LLC will pay Johnson & Johnson’s J&J Surgical Vision Inc $199 million to settle legal battles over intellectual property related to the c[...]
Read more
Business Health Technology US
« Previous 1 … 32 33 34 35 36 … 52 Next »
Wealth Growth Daily
PRIVACY POLICY

Copyright © 2026 Wealth Growth Daily. All Rights Reserved.

HIGH RISK WARNING

Trading foreign exchange, stocks, options, or futures on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to trade, you should carefully consider your objectives, financial situation, needs and level of experience. Wealth Growth Daily provides general advice that does not take into account your objectives, financial situation or needs. The content of this website must not be construed as personal advice. The possibility exists that you could sustain a loss in excess of your deposited funds and therefore, you should not speculate with capital that you cannot afford to lose. You should be aware of all the risks associated with trading on margin. You should seek advice from an independent financial advisor. Past performance is not necessarily indicative of future success.

101 Marketside Ave. Suite 404 PMB 318 Ponte Vedra, FL 32081 | (321) 325-1551